click below
click below
Normal Size Small Size show me how
Anti-Psych PHM1810
Pharmacology I - Chapter 4: Nervous System Drugs, De More
| Question | Answer |
|---|---|
| Acetylcholine | neurotransmitter; major role in cognitive fuction, memory formation and motor control |
| Anorexia nervosa | eating disorder; psychological fear of being overweight; body image is distorted |
| Antidepressants | drugs used to treat depression |
| Antipsychotic drugs | major therapuetic modality for psychotic disorders; aka neuroleptic drugs |
| Bipolar Disorder | mental illness characterized by periods of mania and deep depression |
| Bulimia Nervosa | eating disorder characterized by recurrent (at least twice a week) episodes of binge eating, during which the patient consumes large amaounts of food and feels unable to stop eating; patient purges or abuses laxitives/diuretics/exercise to lose the weight |
| Dementia | a chronic deterioration of intellectual finction and other cognitive skills severe enough to interfere with the ability to perform activities of daily living |
| Depression | mood disorder characterized by low mood |
| Dopamine | a neurotransmitter that occurs naturally produced in the brain, affecting motor control, memory, attention span, problem solving ability, motivation, pleasure and creative thought |
| Extrapyramidial | nerves in the brain that control movement |
| Gamma-aminobutyric Acid - GABA | a neurotransmitter distributed throughout the brain and spinal cord; now considered to be a major inhibitory neurotransmitter in the CNS, acting to modulate the activity of excitatory pathays |
| Glutamate | an amino acid that acts as a neurotransmitter and is a key molecule in cellular metabolism, playing an important role in the body"s disposal of excess or waste nitrogen |
| Hallucinations | false or distorted sensory experiences that appear to be real perceptions |
| Mania | a severe medical conditioncharacterized by extremely elevated mood, energy and unusual thought patterns; characteristic of bipolar disorder |
| Monoamine oxidase inhibitor (MAOI) | class of drug used in the treatment of depression |
| Neuroleptic drugs | major therapuetic modality for psychotic disorders; aka antipsychotic drugs |
| Neurotransmitter | biochemical that is formed in and released form a neuron in order ot stimulate or inhibit the actions of another cell |
| Nocturnal enuresis | nighttime bedwetting |
| Norepinephrine | a neurotransmitter that regulates appetite, sleep, arousal, mood, temperature and hormone release |
| Schizophrenia | a mental illness characterized by distortion of reality, disorganized thought patterns, social withdrawl, hallucinations and poor judgement |
| Selective Seratonin Reuptake Inhibitor (SSRI) | a class of drugs used as antidepressants; block reabsorption of seratonin in nerve cells in the brain |
| Seratonin | a neurotransmitter that regualtes appetite, sleep, arousal, mood, temperature and hormone release |
| Seratonin Syndrome | seratonin toxicity; occurs with an overuse of seratonin (self-posoning, therapuetic overuse, inadvertent adverse effect) which can include servere symptoms such as fever confusion, muscle twitching hallucination etc up to coma and death |
| Tricyclic Anti-Depressant (TCA) | class of antidepressants that inhibit reabsorption of seratonin, dopamine and norepinephrine in the brain |